The board of one of the largest Lithuanian furniture companies Vilniaus baldai, AB proposes to allocate 34,976 million litas for the interim dividends (9 litas per share). The Shareholders\u2019 meeting which is being convened on 16th Aug 2013 will be asked to vote on the distribution of dividends.<\/p>\n
The Shareholders will also be voting on the approval of first half-year report and electing the Audit Committee of Vilniaus baldai, AB. <\/p>\n
The proposed candidates are: Tomas Bubinas, Chief Operating Officer at Biotechpharma (to be appointed as the independent member), Vaidas Savukynas, CFO at Invalda Privatus Kapitalas, AB and Andrius Dauk\u0161as, the Investment manager at Invalda LT, AB. <\/p>\n
The first half sales of ,Vilniaus baldai, AB reached 68,321 million litas \u2013 41 per cent less than during the same period in 2012 (115,398 million litas). Vilniaus baldai, AB earned a net profit of 5,247 million litas over the first half year of 2013, wherea\u2018s the net profit of the same period last year reached 10,858 million litas.<\/p>\n
The investment company Invalda LT controls 45,4 per cent of ,Vilniaus baldai\u2018 shares and Invalda privatus kapitalas has 40,7 per cent stake. <\/p>\n","protected":false},"excerpt":{"rendered":"
The board of one of the largest Lithuanian furniture companies Vilniaus baldai, AB proposes to allocate 34,976 million litas for the interim dividends (9 litas per share). The Shareholders\u2019 meeting..<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[14],"tags":[6],"class_list":["post-14311","post","type-post","status-publish","format-standard","hentry","category-group-company-press-releases","tag-imported"],"acf":[],"yoast_head":"\n